Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed, Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02967276
What this trial is testing

Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Campinas, Brazil 28
Large-scale testing (Phase 3)Study completedNCT00002878
What this trial is testing

Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group
Early research (Phase 1)Ended earlyNCT03710915
What this trial is testing

HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapsed and Refractory Multiple Myeloma
HitGen Inc. 3
Early research (Phase 1)Active Not RecruitingNCT04756726
What this trial is testing

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma, Non-Hodgkin's
C4 Therapeutics, Inc. 224
Not applicableWithdrawnNCT03492268
What this trial is testing

Safety and Efficacy Evaluation of BCMA-CART for Treating Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bioray Laboratories
Testing effectiveness (Phase 2)Study completedNCT01421186
What this trial is testing

A Phase 1/2a Study of Human Anti-CD 38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
MorphoSys AG 91
Testing effectiveness (Phase 2)Ended earlyNCT00567229
What this trial is testing

Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center 3
Early research (Phase 1)Study completedNCT01432353
What this trial is testing

DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genentech, Inc. 39
Testing effectiveness (Phase 2)Ended earlyNCT05172596
What this trial is testing

PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals 146
Not applicableStudy completedNCT01430546
What this trial is testing

Non-interventional Study on Time to Response and Quality of Life in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide in Second Line

Who this might be right for
Multiple Myeloma
Hareth Nahi 133
Testing effectiveness (Phase 2)Active Not RecruitingNCT04392037
What this trial is testing

Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone

Who this might be right for
Multiple Myeloma
Amsterdam UMC, location VUmc 60
Very early researchUnknownNCT04412889
What this trial is testing

BCMA/CD19 Dual-Target CAR-T Cell Immunotherapy for Relapsed or Refractory MM

Who this might be right for
Multiple Myeloma
Hebei Yanda Ludaopei Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT06232096
What this trial is testing

MBS314 in Participants With Relapsed/Refractory Multiple Myeloma.

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Beijing Mabworks Biotech Co., Ltd. 154
Testing effectiveness (Phase 2)Study completedNCT00558675
What this trial is testing

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

Who this might be right for
Hematological MalignancyLeukemiaLymphoma+1 more
Mirror Biologics, Inc. 6
Early research (Phase 1)Ended earlyNCT04142619
What this trial is testing

Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01)

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Cellectis S.A. 11
Testing effectiveness (Phase 2)Study completedNCT01955434
What this trial is testing

SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Mayo Clinic 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04925193
What this trial is testing

Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in Relapse
University of Colorado, Denver 18
Testing effectiveness (Phase 2)WithdrawnNCT00085345
What this trial is testing

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Stage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm
Oncotherapeutics
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Very early researchUnknownNCT04182581
What this trial is testing

BCMA/CD19 Dual-Target CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Xijing Hospital 18
Next Page